Hindson Benjamin J. 的 Form 4 申報

10x Genomics, Inc.（TXG），2022/1/5 申報

申報編號: 0001567619-22-000621
申報時間: 2022/1/5
交易日: 2022/1/3
申報延遲: 2 天
10b5-1 計畫: 表單沒有這欄（2023 年以前）

SEC EDGAR 原文（在新分頁開啟）

這份申報列了 8 筆非衍生性交易、2 筆衍生性交易。公開市場賣出合計 $608.6 萬。交易後 2 天申報。

申報人

一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人	與公司的關係
Hindson Benjamin J.CIK 0001786391	董事、高階主管（見申報備註）

非衍生性證券（表 I）

普通股等股票的取得與處分，每一列是申報上的一筆。

非衍生性證券的交易
交易日	證券	交易	股數	價格	金額	交易後持股	持有方式
2022/1/3	Class A Common Stock	M行使選擇權取得	+2,084	$11.48	+$23,924.32	162,770	直接
2022/1/3	Class A Common Stock	M行使選擇權取得	+39,582	$74.58	+$2,952,025.56	202,352	直接
2022/1/3	Class A Common Stock	S賣出處分	−2,300	$144.56^F2	−$332,488	200,052	直接
2022/1/3	Class A Common Stock	S賣出處分	−16,464	$145.43^F3	−$2,394,359.52	183,588	直接
2022/1/3	Class A Common Stock	S賣出處分	−17,396	$146.29^F4	−$2,544,860.84	166,192	直接
2022/1/3	Class A Common Stock	S賣出處分	−2,906	$147.34^F5	−$428,170.04	163,286	直接
2022/1/3	Class A Common Stock	S賣出處分	−2,000	$148.44^F6	−$296,880	161,286	直接
2022/1/3	Class A Common Stock	S賣出處分	−600	$149.24^F7	−$89,544	160,686	直接

衍生性證券（表 II）

選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。

衍生性證券的交易
交易日	證券	交易	標的股數	單價	金額	交易後持有	持有方式	旗標
2022/1/3	Class A Common Stock	M行使選擇權處分	−2,084	$0.00	$0	31,250	直接
2022/1/3	Class A Common Stock	M行使選擇權處分	−39,582	$0.00	$0	93,630	直接

附註與備註

本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。

This transaction was executed in multiple trades at prices ranging from $143.89 to $144.85. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

表 I 有 1 筆交易的價格引用這則附註。

This transaction was executed in multiple trades at prices ranging from $144.89 to $145.88. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

表 I 有 1 筆交易的價格引用這則附註。

This transaction was executed in multiple trades at prices ranging from $145.89 to $146.8725. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

表 I 有 1 筆交易的價格引用這則附註。

This transaction was executed in multiple trades at prices ranging from $146.89 to $147.87. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

表 I 有 1 筆交易的價格引用這則附註。

This transaction was executed in multiple trades at prices ranging from $147.93 to $148.925. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

表 I 有 1 筆交易的價格引用這則附註。

This transaction was executed in multiple trades at prices ranging from $149.09 to $149.47. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

表 I 有 1 筆交易的價格引用這則附註。

備註

Chief Scientific Officer and President

看 SEC EDGAR 上的完整原文（在新分頁開啟）